Request Demo
Last update 12 Apr 2025
CTA-30X
Last update 12 Apr 2025
Overview
Basic Info
Drug Type Universal CAR-T |
Synonyms CTA30X cell injection, CTA30X UCAR-T, CTA 30X + [1] |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with CTA-30XNCT05015972
A Study of CTA30X UCAR-T Cell Injection in the Treatment of Patients With r/r CD19+ B Hematologic Malignancies
NCT04689204
A Study of CTA30X Cell Injection in the Treatment of Relapsed or Refractory CD19-positive B-line Hematological Malignancies
100 Clinical Results associated with CTA-30X
Login to view more data
100 Translational Medicine associated with CTA-30X
Login to view more data
100 Patents (Medical) associated with CTA-30X
Login to view more data
100 Deals associated with CTA-30X
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Malignant Neoplasm | Phase 1 | China | 20 Aug 2021 | |
| CD19 Expressing Malignancies | Phase 1 | China | 20 Aug 2021 | |
| CD19-positive B-cell acute lymphoblastic leukemia | Phase 1 | China | 29 Dec 2020 | |
| Diffuse Large B-Cell Lymphoma | Phase 1 | China | 29 Dec 2020 | |
| Diffuse large B-cell lymphoma recurrent | Phase 1 | China | 29 Dec 2020 | |
| Diffuse large B-cell lymphoma refractory | Phase 1 | China | 29 Dec 2020 | |
| Follicular Lymphoma | Phase 1 | China | 29 Dec 2020 | |
| High grade B-cell lymphoma | Phase 1 | China | 29 Dec 2020 | |
| Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia | Phase 1 | China | 29 Dec 2020 | |
| Pre B-cell acute lymphoblastic leukemia | Phase 1 | China | 29 Dec 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free